Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00698659
What this trial is testing

Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies

Who this might be right for
HypertensionProteinuria
National University Hospital, Singapore
Testing effectiveness (Phase 2)Study completedNCT01263782
What this trial is testing

BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 64
Not applicableStudy completedNCT07663370
What this trial is testing

Effectiveness of Biosimilar Ranibizumab in the Management of Diabetic Macular Edema

Who this might be right for
Anti-VEGF TreatmentRanibizumabBiosimilar
Benha University 60
Testing effectiveness (Phase 2)Study completedNCT01472510
What this trial is testing

Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy

Who this might be right for
Diabetic Macular Edema
Vitreo-Retinal Associates, PC 20
Not applicableStudy completedNCT07144865
What this trial is testing

Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection

Who this might be right for
Proliferative Diabetic Retinopathy
Bojie Hu 8
Post-approval studies (Phase 4)Study completedNCT02036424
What this trial is testing

Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Raj K. Maturi, MD 45
Testing effectiveness (Phase 2)Study completedNCT03744767
What this trial is testing

Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Dr Irmela MANTEL 20
Early research (Phase 1)Ended earlyNCT00704821
What this trial is testing

PTC299 for Treatment of Advanced Cancer

Who this might be right for
Advanced Cancer
PTC Therapeutics 76
Testing effectiveness (Phase 2)Study completedNCT01115556
What this trial is testing

A Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With Persistent/Recurrent Macular Fluid Less Than 30 Days Following Treatment With Intravitreal Anti-VEGF Therapy (the LAST Study)

Who this might be right for
Age Related Macular Degeneration
Vitreous -Retina- Macula Consultants of New York 9
Post-approval studies (Phase 4)Looking for participantsNCT07133438
What this trial is testing

Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment

Who this might be right for
Retinal Vein Occlusion (RVO)
First Affiliated Hospital of Chongqing Medical University 120
Large-scale testing (Phase 3)Study completedNCT03321513
What this trial is testing

DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME

Who this might be right for
Diabetic Macular Edema
Jaeb Center for Health Research 270
Large-scale testing (Phase 3)Study completedNCT04288232
What this trial is testing

Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan

Who this might be right for
Center-involved Diabetic Macular Edema
Taipei Veterans General Hospital, Taiwan 45
Not applicableStudy completedNCT04982484
What this trial is testing

Reading Speed Improvements in Wet-AMD Patients After Ranibizumab Treatment

Who this might be right for
OphthalmopathyWet Macular Degeneration
Centre Hospitalier Régional Metz-Thionville 50
Early research (Phase 1)Study completedNCT02665416
What this trial is testing

Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Hoffmann-La Roche 94
Not applicableStudy completedNCT06878573
What this trial is testing

Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic Macula Edema

Who this might be right for
Age Related Macular DegenerationDiabetic Macular Edema
Augenabteilung Allgemeines Krankenhaus Linz 36
Not applicableNot Yet RecruitingNCT07009574
What this trial is testing

The Treatment Burden of Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularisationAnti-VEGF TreatmentBurden
Policlinico Gaspare Rodolico - San Marco Catania 100
Large-scale testing (Phase 3)Study completedNCT00028990
What this trial is testing

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 722
Testing effectiveness (Phase 2)Ended earlyNCT01264341
What this trial is testing

Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
Hellenic Cooperative Oncology Group 39
Large-scale testing (Phase 3)Ended earlyNCT04611152
What this trial is testing

A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Kodiak Sciences Inc 460
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06196775
What this trial is testing

Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Harbin Medical University 36
Next Page